Literature DB >> 28379638

Meeting report: Vitiligo Global Issues Consensus Conference Workshop "Outcome measurement instruments" and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd.

Nanja van Geel1, Katia Boniface2,3, Julien Seneschal2,3, Clément Jacquemin2,3, Reinhart Speeckaert1, Albert Wolkerstorfer4, Marcel Bekkenk4, Janny E Lommerts4, Iltefat Hamzavi5, Amit Pandya6, Viktoria Eleftheriadou7, Khaled Ezzedine8, Diana Giannarelli9, Maria Gnarra9, Isabella Sperduti9, Cecilia Prinsen10, John Harris11, Alain Taieb2,3, Mauro Picardo9.   

Abstract

Mesh：

Year:  2017        PMID： 28379638     DOI： 10.1111/pcmr.12593

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  4 in total

Review 1.  [Systemic treatment of vitiligo : Balance and current developments].

Authors:  M Meurer; P Ceric-Dehdari
Journal:  Hautarzt       Date:  2017-11       Impact factor: 0.751

2.  Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.

Authors:  Nanja van Geel; Iltefat H Hamzavi; Amit G Pandya; Albert Wolkerstorfer; Julien Seneschal; Amit Garg; Phyllis Spuls; Caroline B Terwee; Sue Mallett; Reinhart Speeckaert; Jean Marie Meurant; Viktoria Eleftheriadou; Khaled Ezzedine
Journal:  Trials       Date:  2022-07-23       Impact factor: 2.728

3.  Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS).

Authors:  N van Geel; L Depaepe; V Vandaele; L Mertens; J Van Causenbroeck; S De Schepper; L Van Coile; A Van Reempts; A-S De Vos; J Papeleu; I Hoorens; D Mertens; A Wolkerstorfer; J E Lommerts; R Speeckaert
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-04-29       Impact factor: 9.228

4.  Reliability and validity of the Vitiligo Signs of Activity Score (VSAS).

Authors:  N van Geel; T Passeron; A Wolkerstorfer; R Speeckaert; K Ezzedine
Journal:  Br J Dermatol       Date:  2020-03-29       Impact factor: 9.302
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.